Disposable Medical Sensors Market Companies
- Abbott
- Dexcom
- Medtronic
- Roche Diagnostics
- Siemens Healthineers
- Johnson & Johnson / LifeScan
- Becton, Dickinson & Co. (BD)
- Masimo
- Nihon Kohden
- 3M (3M Healthcare)
- Cardinal Health / Medline
- iRhythm Technologies
- Philips
- BioTelemetry
- VitalConnect
- BioIntelliSense
- Trividia Health / ACON
- Nova Biomedical
- BD / Alere / Abbott
- OEM sensor module & chemistry suppliers
Market Growth
The global disposable medical sensors market size is calculated at US$ 13.12 billion in 2024, grew to US$ 15.55 billion in 2025, and is projected to reach around US$ 71.62 billion by 2034. The market is expanding at a CAGR of 18.54% between 2025 and 2034.
Drifts in the Disposable Medical Sensors Market
- The global market is focusing on raising patient comfort and convenience with wearable and flexible sensors, which is mainly impacting the overall demand for innovations in disposable medical sensors.
- In June 2025, PharmaSens and SiBionics entered into a development collaboration to advance an all-in-one patch pump for diabetes management.
- In April 2025, Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, secured $100 million in Series C funding for an intradermal glucose sensor for type 2 diabetes.
- In February 2025, Level Zero Health closed an oversubscribed $6.9M funding round to prove wearable medtech can take the strain out of hormone testing.
The Market Value Chain Analysis
R&D
The disposable medical sensors market has major R&D stages, including a significant start from conceptualization and feasibility studies for a certain need, going through prototype design and development, and then to rigorous design and material qualification for disposability and function.
Key Players: Dexcom, Inc., Gentag, Inc., Starboard Medical Inc., and SSI Electronics, etc.
Clinical Trials and Regulatory Approvals
This mainly comprises the beginning of preclinical research (bench testing, simulations, animal studies), followed by the submission of an Investigational New Drug (IND) for human trials.
Key Players: Stryker Sustainability Solutions, Sheba Medical Center, and The Cleveland Clinic, etc.
Patient Support and Services
The disposable medical sensors market is accelerating patient support and services by facilitating continuous, real-time monitoring outside clinical settings, optimizing diagnostic accuracy, and reducing hospital-acquired infections (HAIs) through single-use, sterile applications.
Key Players: Medtronic, Philips Healthcare, Abbott Laboratories, GE Healthcare, etc.
Latest Announcements by Industry Leaders
- In March 2025, Nanowear, a leader in home-based cardiometabolic digital diagnostics, announced a collaboration with Dexcom for SimpleSense™, a nanotechnology-enabled wearable, mobile, and software diagnostics platform. Venk Varadan, CEO and Co-founder of Nanowear, said that this will offer Nanowear-Dexcom integration and a data partnership in a unique clinical research.
- In July 2024, Fitterfly Healthtech announced a partnership with Ascensia Diabetes Care to improve diabetes management. Albertraj Balraj, Country Head and Director at Ascensia Diabetes Care India Pvt Ltd., commented that this will empower people living with diabetes through novel measures that streamline and improve their lives.
Recent Developments in the Disposable Medical Sensors Market
- In August 2025, Signos launched the first-ever FDA-cleared, over-the-counter glucose monitoring system designed specifically for weight management.
- In July 2025, Trividia Health, Inc. launched its TRUE METRIX® blood glucose meter and test strips for Pennsylvania medicaid recipients.
- In January 2025, a global leader in process analysis and optimization solutions introduced its latest breakthrough in oxygen analysis technology.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
